Oxford Biomedica plc (OXB) Ordinary 50p
16.20p
(8.89%)
- Add to watchlist
- Create an alert
- This stock can be held in a
16.20p
(8.89%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
16.20p
(8.89%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
182.80p
200.50p
575.00p
£192.06 million
182.20p
180.73p
164.40p
n/a
2.40p (1.33%) Previous:
2.40p
669,164
n/a
3,000
Performance
| 1 week 1W | 18.94% | 1 year 1Y | 48.13% |
|---|---|---|---|
| 1 month 1M | 6.85% | 2 years 2Y | 84.13% |
| 3 months 3M | 35.79% | 3 years 3Y | 76.6% |
| 6 months 6M | 56.96% | 5 years 5Y | 72.14% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
| Year ending: | 31/12/2022 | 31/12/2021 |
|---|---|---|
| Revenue (£m) | 139.99 | 142.80 |
| Profit before tax (£m) | (45.98) | 19.88 |
| Adjusted EPS (p): | (41.29) | 22.77 |
| P/E ratio | n/a | 54.00 |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Director dealings: TUI, Oxford Biomedica board members linked to buys
27 September 2023 11:24
-
Liberum cuts target price for Oxford Biomedica, saying it still lacks sufficient scale
28 November 2022 11:43
-
Oxford Biomedica taps Frank Mathias as its new CEO
22 November 2022 09:30
-
Business Update
7 December 2023 07:00
-
Signing of agreement to acquire ABL Europe
4 December 2023 07:00
-
Total Voting Rights
1 December 2023 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.